CN Patent

CN101622001A — 作为激酶抑制剂用于治疗疟原虫相关疾病的嘌呤化合物和组合物

Assigned to IRM LLC · Expires 2010-01-06 · 16y expired

What this patent protects

本发明提供了一类嘌呤化合物、含有此类化合物的药用组合物以及使用此类化合物治疗或预防与激酶活性有关的疾病或病症、特别是疟疾的方法。

USPTO Abstract

本发明提供了一类嘌呤化合物、含有此类化合物的药用组合物以及使用此类化合物治疗或预防与激酶活性有关的疾病或病症、特别是疟疾的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101622001A
Jurisdiction
CN
Classification
—
Expires
2010-01-06
Drug substance claim
No
Drug product claim
No
Assignee
IRM LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.